Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial

Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect the closure of a study as of Amendment 11, allowing eligible participants to receive sotatercept through an extension study or commercial access. Additionally, the number of study locations has increased from 149 to 152, and specific locations in Taiwan have been added.
    Difference
    17%
    Check dated 2025-02-22T19:59:22.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, along with a notice about potential performance issues due to heavy traffic.
    Difference
    0.6%
    Check dated 2025-02-08T08:13:30.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-23T22:48:23.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The website has added numerous contact numbers for study coordinators while removing the previous type of intervention and updating the revision from v2.13.3 to v2.14.0.
    Difference
    11%
    Check dated 2025-01-14T18:56:33.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-17T00:16:50.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information on who to contact for questions about joining the study and where it is taking place, with a revision from v2.12.2 to v2.13.2.
    Difference
    1%
    Check dated 2024-12-09T21:14:26.000Z thumbnail image

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.